CJC-1295 without DAC is a short-acting GHRH analogue that stimulates pulsatile GH release. It is investigated for GH axis physiology and growth hormone-related research.
| Molecular Weight | 3367.0 g/mol |
| Purity | >98% |
| Form | Lyophilized powder |
| Storage | -20°C |
Science-backed research overview for this compound
CJC-1295 No DAC (also known as Modified GRF 1-29) is a synthetic analogue of the naturally occurring Growth Hormone Releasing Hormone (GHRH). It is composed of the first 29 amino acids of GHRH, which are the ones responsible for its biological activity.
Unlike the DAC version, CJC-1295 No DAC has a short half-life of about 30 minutes. This allows researchers to mimic the body's natural "pulsatile" release of Growth Hormone. It signals the pituitary to release a surge of GH, which then returns to baseline, preventing the "bleeding" of GH levels seen with long-acting versions.
CJC-1295 No DAC is studied for its ability to improve protein synthesis, enhance muscle recovery, and support fat loss. It is frequently researched in combination with Ipamorelin to create a more powerful, multi-pathway surge of Growth Hormone for advanced tissue regeneration studies.